"Medical Speed Reading Society" Yan Jian announces new data on Spinraza Benvimod cream price reduction

23 pharmaceutical companies enter the 2020 Fortune 500
On May 18th, from 0 to 24 hours, 31 provinces (autonomous regions, municipalities directly under the central government) and Xinjiang Production and Construction Corps reported 6 new confirmed cases, including 3 cases imported from abroad (3 cases in Inner Mongolia) and 3 cases of local cases (2 cases in Jilin, 1 case in Hubei); (The official website of the National Health and Health Commission)19, the State Drug Administration issued the 2020 medical device industry standard revision plan project noticeThe circular aims to implement the Opinions of the General Office of the CPC Central Committee and the General Office of the State Council on Deepening the Reform of the Review and Approval System to Encourage Innovation in Pharmaceutical Medical Devices, and to revise the work requirements of the standard system for medical devices in the 13th Five-Year Plan for Drug Safety(State Drug Administration)recently, Suzhou City Health Insurance Bureau issued a request for comments on the "Suzhou City Fixed-point Outpatient Department, Clinic Credit Rating Evaluation Management Measures (Trial)" to amend the draft, Sword refers to strengthening the supervision of medical security funds, strengthen the fixed-point outpatient departments, clinics self-discipline and integrity awareness, guide the integrity of the practice in accordance with the law, the "Measures" from July 1, 2020(Suzhou City Health Insurance Bureau)18, Liaoning Province, drugs and medical supplies centralized procurement network issued "on the suspension of some drugs online procurement publicity." According to combing, the suspension of procurement of unreviewed drugs have 65 kinds, involving finaea, katopli tablets, acetaminophen tablets, metformin hydrochloride tablets, hydrochloric acid metformin tablets, cirate citrilin tablets and so on(Liaoning Province, medicine and medical supplies centralized procurement network)Fortune magazine globally released the 2020 U.STop 500 companies ranking, this year's top 500 companies accounted for two-thirds of the U.Seconomy, total revenue of $14.2 trillion, up 3.5 percent from last year, total profit of $1.2 trillion, up nearly 8 percent from last year, including health care companies leading other industries, up 12 percentA total of 23 medical and pharmaceutical companies, including Johnson and Johnson, Pfizer and MSD, made the list(Pharmaceutical representative)18, Jinfa Technology Co., Ltdannounced that its subsidiary Guangdong Blonde Technology Co., Ltdrecently received a U.S company KN95 mask purchase order, the order amount of 975 million U.S dollars, equivalent to about 6.94 billion yuan (Seiber Blue Devices) 18, by GlaxoSmithKline Holdings, Pfizer and Yannoyi as shareholders of ViiVHealthcare announced a long-acting injection drug cabotegravir prevention of AIDS safety and efficacy test positive interim results The data showed that cabotegravir was 69% effective in preventing male behavior and sexual lying with men compared to the current standard of care, daily oral attathan/fumastine-inofevir The study reached the main end of the non-disadvantage (Sina Pharmaceutical News) Moderna corporation announced that the new coronavirus vaccine mRNA-1273 in phase 1 clinical research achieved positive interim results mRNA-1273 showed good safety, and in all volunteers who received two doses of 25 ?g and 100 ?g, new coronavirus binding antibodies were produced with levels comparable to those in the serum of the recovered person Also, in eight volunteers who were able to assess neutralizing antibody levels, all of the volunteers had neutralizing antibody levels in their blood or exceeding the neutral antibody levels in the serum of the recovering Vir Biotechnology, the , announced that its study of the new coronavirus neutralizing antibodies was published in the journal Nature in an accelerated preview In this study, monoclonal antibodies called S309, screened from patients recovering from SARS virus infection, were able to prevent neo-coronavirus infection in in vitro trials Based on this antibody, Vir has partnered with GlaxoSmithKline to develop two new coronavirus antibody therapies, VIR-7831 and VIR-7832 The U.S FDA announced approval of Tecentriq Extended Indications, developed by Roche's Gene Tektronix, a single-drug first-line treatment of adult patients with highly expressive metastatic non-small cell lung cancer in adult patients whose tumors do not carry eGFR or ALK gene variants This is Tecentriq's fourth indication in the NSCLC field, genetek's press release said Yan Jian recently released additional data on the clinical development of spinelmuscular amyotrophic drug Spinraza (nusinersen), further enhancing the continued efficacy and long-term safety of Spinraza in improving or stabilizing motor function in a wide range of age groups and in patients with different types of SMA (Sina Pharmaceutical News) , Yangsen Pharmaceuticals announced the results of phase 1 clinical CHRYSALIS study, which evaluated the efficacy of amivantamab for patients with advanced non-small cell lung cancer (NSCLC) used by amivantamab for epidermal growth factor receptor (EGFR) exosome 20 insertion mutation The results showed that amivantamab had a strong and long-lasting effect on Patients with EGFR20 exon insertion mutation nSCLC, and the safety was controllable (Sina Pharmaceutical News) Yangsen Pharmaceuticals recently reported for the first time the results of the phase I human dose increase study ( JNJ-64007957, JNJ-7957) teclistamab is a bispecific antibody targeted by B-cell mature antigens and T-cell CD3 receptors, and the study evaluated teclistamab to treat patients with relapsed or refractory multiple myeloma with over-pre-treatment (Bio Valley) Cinda Biopharma and mDAnderson Cancer Center at the University of Texas in the United States announced a strategic partnership to jointly develop the anti-PD-1 monoclonal antibody Damershu ® (Sindilli monoantigen) in the United States for the treatment of a variety of rare cancers Excelra, the world's leading data and analysis company , will provide GOSTAR to Lawrence Livermore National Laboratory under a three-year agreement GOSTAR is a small molecular pharmaceutical chemical intelligence database that supports drug design projects The platform will help accelerate the Medical Research and Development Program alliance's goal of significantly reducing drug discovery cycles from six to one year Exyte and Univercells Technologies jointly announced a global partnership to optimize the modular, standardized and flexible construction of GMP standard vaccine production facilities (American News Agency) 18, Shaanxi Province Public Resources Trading Center issued a notice, according to the enterprise application, will now Bendigo Pharmaceutical Co., Ltd production of BenVimode cream (drug number: 8200594, specifications: 10g:0.1g (1%)) hanging network limit price from 546 yuan to 496 yuan, adjusted price from now on (Shanxi Provincial Public Resources Trading Center)